Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Ikarian Capital

Latest statistics and disclosures from Ikarian Capital's latest quarterly 13F-HR filing:

Top 5 stock holdings are VRTX, AMGN, XBI, TARS, BGNE, and represent 34.56% of Ikarian Capital's stock portfolio.
Added to shares of these 10 stocks: VRTX (+$93M), XBI (+$49M), AMGN (+$39M), BGNE (+$27M), ANAB (+$25M), CLDX (+$21M), JANX (+$17M), BHVN (+$16M), VRDN (+$16M), CAPR (+$14M).
Started 40 new stock positions in Biomx, DYN, EOLS, ANAB, JANX, RLAY, GLUE, HOOK, PRTA, NMRA.
Reduced shares in these 10 stocks: , PRAX (-$30M), SRPT (-$19M), NUVL (-$10M), ARE (-$8.6M), AZN (-$8.5M), CRNX (-$8.3M), VKTX (-$7.3M), CORT (-$6.0M), SLNO (-$5.8M).
Sold out of its positions in ARE, ANNX, ANVS, ARQT, AZN, BCLI, CORT, CYBN, G1 Therapeutics, NBIX. PRAX, QTTB, VRNA, VKTX.
Ikarian Capital was a net seller of stock by $-219M.
Ikarian Capital has $735M in assets under management (AUM), dropping by -91.18%.
Central Index Key (CIK): 0001778253

Tip: Access up to 7 years of quarterly data

Positions held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Ikarian Capital

Ikarian Capital holds 121 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Vertex Pharmaceuticals Incorporated Put Option (VRTX)	12.6	$93M	NEW	200k	465.08	View chart
Amgen Call Option (AMGN)	7.0	$51M	+309%	159k	322.21	View chart
Spdr Ser Tr S&p Biotech Put Option (XBI)	6.7	$49M	NEW	500k	98.80	View chart
Tarsus Pharmaceuticals (TARS)	4.6	$34M	+28%	1.0M	32.89	View chart
Beigene Sponsored Adr Call Option (BGNE)	3.6	$27M	NEW	118k	224.51	View chart
Anaptysbio Inc Common Put Option (ANAB)	3.4	$25M	NEW	754k	33.50	View chart
Crinetics Pharmaceuticals In (CRNX)	3.0	$22M	-27%	427k	51.10	View chart
Celldex Therapeutics Com New Put Option (CLDX)	2.8	$21M	NEW	611k	33.99	View chart
Soleno Therapeutics Call Option (SLNO)	2.3	$17M	-25%	331k	50.49	View chart
Janux Therapeutics Put Option (JANX)	2.3	$17M	NEW	365k	45.43	View chart
Biohaven Put Option (BHVN)	2.2	$16M	NEW	326k	49.97	View chart
Miragen Therapeutics Call Option (VRDN)	2.2	$16M	+18373%	700k	22.75	View chart
Immunovant Call Option (IMVT)	1.9	$14M	+79%	500k	28.51	View chart
Capricor Therapeutics Com New Put Option (CAPR)	1.9	$14M	NEW	900k	15.21	View chart
Arcus Biosciences Incorporated Call Option (RCUS)	1.8	$13M	+491%	858k	15.29	View chart
Corbus Pharmaceuticals Hldgs Com New Put Option (CRBP)	1.8	$13M	+102%	626k	20.63	View chart
Enliven Therapeutics (ELVN)	1.7	$13M	-14%	500k	25.54	View chart
Cytokinetics Com New Call Option (CYTK)	1.6	$12M	+30%	222k	52.80	View chart
Insmed Com Par $.01 (INSM)	1.5	$11M	+188%	155k	73.00	View chart
Neumora Therapeutics Put Option (NMRA)	1.4	$11M	NEW	800k	13.21	View chart
Apellis Pharmaceuticals Put Option (APLS)	1.4	$10M	NEW	350k	28.84	View chart
Alto Neuroscience Com Shs Put Option (ANRO)	1.4	$10M	NEW	881k	11.44	View chart
Ultragenyx Pharmaceutical (RARE)	1.4	$9.9M	NEW	179k	55.55	View chart
Avalo Therapeutics Com New (AVTX)	1.3	$9.2M	+1672%	970k	9.50	View chart
Spyre Therapeutics Com New (SYRE)	1.2	$8.9M	NEW	302k	29.41	View chart
Catalyst Pharmaceutical Partners (CPRX)	1.1	$8.3M	-19%	418k	19.88	View chart
Tectonic Therapeutic (TECX)	1.1	$8.1M	+325%	267k	30.30	View chart
Blueprint Medicines (BPMC)	1.1	$7.9M	NEW	85k	92.50	View chart
Bridgebio Pharma (BBIO)	1.0	$7.3M	-15%	286k	25.46	View chart
Black Diamond Therapeutics Put Option (BDTX)	1.0	$7.2M	NEW	1.7M	4.35	View chart
Sarepta Therapeutics (SRPT)	0.9	$6.8M	-73%	54k	124.89	View chart
Nurix Therapeutics (NRIX)	0.8	$5.8M	-40%	260k	22.47	View chart
Akero Therapeutics Put Option (AKRO)	0.8	$5.7M	NEW	199k	28.69	View chart
Sana Biotechnology Put Option (SANA)	0.7	$5.4M	+16150%	1.3M	4.16	View chart
Nuvalent Inc-a (NUVL)	0.7	$5.3M	-65%	52k	102.30	View chart
Structure Therapeutics Sponsored Ads (GPCR)	0.7	$5.1M	+19762%	115k	43.89	View chart
Madrigal Pharmaceuticals Put Option (MDGL)	0.7	$5.0M	NEW	24k	212.22	View chart
Relay Therapeutics (RLAY)	0.7	$4.9M	NEW	693k	7.08	View chart
Lenz Therapeutics (LENZ)	0.7	$4.9M		205k	23.74	View chart
Pyxis Oncology Common Stock Call Option (PYXS)	0.7	$4.8M	-21%	1.3M	3.67	View chart
Dyne Therapeutics Put Option (DYN)	0.6	$4.8M	NEW	133k	35.92	View chart
Wave Life Sciences SHS (WVE)	0.6	$4.5M	-5%	544k	8.20	View chart
Rezolute Com New (RZLT)	0.6	$4.3M		887k	4.85	View chart
Xenon Pharmaceuticals (XENE)	0.6	$4.2M		107k	39.37	View chart
Evolus (EOLS)	0.6	$4.2M	NEW	258k	16.20	View chart
Abeona Therapeutics Com New (ABEO)	0.5	$3.7M	-24%	584k	6.32	View chart
Rocket Pharmaceuticals (RCKT)	0.5	$3.6M		197k	18.47	View chart
Silence Therapeutics Ads (SLN)	0.5	$3.4M	+15%	587k	5.75	View chart
Acelyrin (SLRN)	0.5	$3.3M	-54%	677k	4.93	View chart
Cybin Com New	0.4	$3.3M	NEW	367k	8.89	View chart
Scholar Rock Hldg Corp Put Option (SRRK)	0.4	$3.2M	+120%	404k	8.01	View chart
Cervomed (CRVO)	0.4	$3.0M	-14%	202k	14.60	View chart
Tourmaline Bio (TRML)	0.4	$2.8M		109k	25.71	View chart
Galectin Therapeutics Com New Put Option (GALT)	0.4	$2.8M	NEW	1.0M	2.75	View chart
Terns Pharmaceuticals (TERN)	0.3	$2.6M	-32%	309k	8.34	View chart
Alnylam Pharmaceuticals (ALNY)	0.3	$2.4M	+191%	8.7k	275.03	View chart
Lexeo Therapeutics (LXEO)	0.3	$2.3M	NEW	257k	9.04	View chart
Mineralys Therapeutics (MLYS)	0.3	$2.2M	NEW	180k	12.11	View chart
Solid Biosciences Com New Call Option (SLDB)	0.3	$2.1M	NEW	300k	6.97	View chart
Fulcrum Therapeutics Put Option (FULC)	0.3	$1.9M	NEW	521k	3.57	View chart
Reneo Pharmaceuticals (RPHM)	0.2	$1.7M	NEW	1.0M	1.70	View chart
Nektar Therapeutics (NKTR)	0.2	$1.7M		1.3M	1.30	View chart
Monte Rosa Therapeutics (GLUE)	0.2	$1.7M	NEW	312k	5.30	View chart
Achilles Therapeutics Sponsored Ads (ACHL)	0.2	$1.5M		1.4M	1.02	View chart
Springworks Therapeutics Call Option (SWTX)	0.2	$1.4M	NEW	44k	32.04	View chart
Ibio Con New (IBIO)	0.2	$1.3M		600k	2.22	View chart
Compass Pathways Sponsored Ads (CMPS)	0.2	$1.3M	-33%	203k	6.30	View chart
Kodiak Sciences (KOD)	0.2	$1.2M		477k	2.61	View chart
Marinus Pharmaceuticals Com New (MRNS)	0.2	$1.2M		706k	1.76	View chart
Roivant Sciences SHS (ROIV)	0.2	$1.2M		101k	11.54	View chart
Corvus Pharmaceuticals Call Option (CRVS)	0.2	$1.2M	NEW	218k	5.28	View chart
Olema Pharmaceuticals (OLMA)	0.1	$1.1M	NEW	92k	11.94	View chart
Inflarx Nv (IFRX)	0.1	$1.1M		705k	1.53	View chart
Sagimet Biosciences Com Ser A (SGMT)	0.1	$1.1M	-6%	388k	2.77	View chart
Jasper Therapeutics Com New (JSPR)	0.1	$1.0M	-47%	55k	18.81	View chart
Perspective Therapeutics Com New Put Option (CATX)	0.1	$1.0M	NEW	77k	13.35	View chart
Biomx Com New	0.1	$911k	NEW	893k	1.02	View chart
Delcath Sys Com New (DCTH)	0.1	$906k		100k	9.03	View chart
Eliem Therapeutics (ELYM)	0.1	$891k	+75%	175k	5.09	View chart
Amylyx Pharmaceuticals (AMLX)	0.1	$890k		275k	3.24	View chart
Proqr Thrapeutics N V Shs Euro (PRQR)	0.1	$880k		484k	1.82	View chart
Cartesian Therapeutics Com New (RNAC)	0.1	$841k	-78%	52k	16.12	View chart
Kezar Life Sciences (KZR)	0.1	$827k	+23%	1.1M	0.77	View chart
Verve Therapeutics (VERV)	0.1	$823k	NEW	170k	4.84	View chart
Immunic (IMUX)	0.1	$814k		494k	1.65	View chart
Iteos Therapeutics (ITOS)	0.1	$802k		79k	10.21	View chart
Aerovate Therapeutics (AVTE)	0.1	$769k		368k	2.09	View chart
Female Health (VERU)	0.1	$728k		946k	0.77	View chart
Lyell Immunopharma (LYEL)	0.1	$726k		526k	1.38	View chart
Milestone Pharmaceuticals (MIST)	0.1	$708k		466k	1.52	View chart
Acumen Pharmaceuticals (ABOS)	0.1	$661k		266k	2.48	View chart
Inhibrx Biosciences (INBX)	0.1	$660k	-81%	42k	15.66	View chart
Allakos (ALLK)	0.1	$635k		973k	0.65	View chart
Immatics SHS (IMTX)	0.1	$564k		49k	11.41	View chart
Biomea Fusion Put Option (BMEA)	0.1	$535k	NEW	53k	10.10	View chart
Nyxoah S A SHS (NYXH)	0.1	$484k		51k	9.55	View chart
Newamsterdam Pharma Company Ordinary Shares Call Option (NAMS)	0.1	$483k	NEW	29k	16.60	View chart
Ventyx Biosciences (VTYX)	0.1	$420k	-56%	193k	2.18	View chart
Elevation Oncology (ELEV)	0.1	$414k		690k	0.60	View chart
Prothena Corp SHS Put Option (PRTA)	0.1	$395k	NEW	24k	16.73	View chart
Sensei Biotherapeutics (SNSE)	0.1	$389k		650k	0.60	View chart
Larimar Therapeutics (LRMR)	0.1	$383k	-81%	59k	6.55	View chart
Mind Medicine Mindmed Com New (MNMD)	0.0	$356k	-61%	63k	5.69	View chart
Karyopharm Therapeutics (KPTI)	0.0	$340k		409k	0.83	View chart
Chemomab Therapeutics Sponsored Ads (CMMB)	0.0	$335k		213k	1.57	View chart
Voyager Therapeutics (VYGR)	0.0	$327k		56k	5.85	View chart
Rapt Therapeutics (RAPT)	0.0	$311k		155k	2.01	View chart
Anebulo Pharmaceuticals (ANEB)	0.0	$305k		158k	1.93	View chart
Apogee Therapeutics Call Option (APGE)	0.0	$294k	NEW	5.0k	58.74	View chart
Protara Therapeutics Com Stk (TARA)	0.0	$285k	-13%	156k	1.83	View chart
Lyra Therapeutics (LYRA)	0.0	$272k		1.1M	0.26	View chart
Aeon Biopharma Cl A (AEON)	0.0	$271k		258k	1.05	View chart
Macrogenics (MGNX)	0.0	$264k	-59%	80k	3.29	View chart
Hookipa Pharma Com New (HOOK)	0.0	$228k	NEW	53k	4.30	View chart
Nuvation Bio Com Cl A (NUVB)	0.0	$191k	-76%	83k	2.29	View chart
Tempest Therapeutics (TPST)	0.0	$148k		106k	1.40	View chart
Relmada Therapeutics (RLMD)	0.0	$131k		40k	3.24	View chart
Stoke Therapeutics (STOK)	0.0	$84k		6.8k	12.29	View chart
Synlogic Com New (SYBX)	0.0	$31k		20k	1.49	View chart
Cytomx Therapeutics (CTMX)	0.0	$11k		8.9k	1.18	View chart
4d Molecular Therapeutics In (FDMT)	0.0	$421.001100	NEW	39.00	10.79	View chart

Past Filings by Ikarian Capital

SEC 13F filings are viewable for Ikarian Capital going back to 2019

Ikarian Capital 2024 Q3 filed Nov. 14, 2024
Ikarian Capital 2024 Q2 filed Aug. 14, 2024
Ikarian Capital 2024 Q1 restated filed May 17, 2024
Ikarian Capital 2024 Q1 filed May 15, 2024
Ikarian Capital 2023 Q4 filed Feb. 14, 2024
Ikarian Capital 2023 Q3 filed Nov. 14, 2023
Ikarian Capital 2023 Q2 filed Aug. 14, 2023
Ikarian Capital 2023 Q1 filed May 15, 2023
Ikarian Capital 2022 Q4 filed Feb. 14, 2023
Ikarian Capital 2022 Q3 filed Nov. 14, 2022
Ikarian Capital 2022 Q2 filed Aug. 12, 2022
Ikarian Capital 2022 Q1 filed May 13, 2022
Ikarian Capital 2021 Q4 filed Feb. 14, 2022
Ikarian Capital 2021 Q3 filed Nov. 15, 2021
Ikarian Capital 2021 Q1 restated filed Aug. 18, 2021
Ikarian Capital 2021 Q2 restated filed Aug. 18, 2021

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z